Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Restructuring Costs (2021 - 2026)

Updated

Theravance Biopharma (TBPH) recorded Restructuring Costs of $4.03 million in Q2 2026, up 11.0% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Restructuring Costs (2021 - 2026) Analysis & Trends

On a TTM basis, Theravance Biopharma's Restructuring Costs came in at $7.66 million as of Jun 30, 2026; for FY2023, it was $2.74 million, down 78.6% from FY2022.

  • Across earlier years, Restructuring Costs came in at $12.84 million in FY2022 (-36.3%) and $20.14 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Restructuring Costs since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.03 Mn
Mar 31, 2026 3.63 Mn
Jun 30, 2023 1.17 Mn
Mar 31, 2023 1.57 Mn
Sep 30, 2022 509,000.00
Jun 30, 2022 3.01 Mn
Mar 31, 2022 9.32 Mn
Dec 31, 2021 18.37 Mn
Sep 30, 2021 1.77 Mn
API Access

Theravance Biopharma Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=TBPH&period=max&api_key=YOUR_API_KEY